Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Use of Electronic Health Records to Develop and Implement a Silent Best Practice Alert Notification System for Patient Recruitment in Clinical Research: Quality Improvement Initiative.

Devoe C, Gabbidon H, Schussler N, Cortese L, Caplan E, Gorman C, Jethwani K, Kvedar J, Agboola S.

JMIR Med Inform. 2019 Apr 26;7(2):e10020. doi: 10.2196/10020.

2.

PKM2 is not required for pancreatic ductal adenocarcinoma.

Hillis AL, Lau AN, Devoe CX, Dayton TL, Danai LV, Di Vizio D, Vander Heiden MG.

Cancer Metab. 2018 Oct 23;6:17. doi: 10.1186/s40170-018-0188-1. eCollection 2018.

3.

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer.

Tiriac H, Belleau P, Engle DD, Plenker D, DeschĂȘnes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, Palmaira RLD, Javed AA, Huynh JC, Johnson M, Arora K, Robine N, Shah M, Sanghvi R, Goetz AB, Lowder CY, Martello L, Driehuis E, LeComte N, Askan G, Iacobuzio-Donahue CA, Clevers H, Wood LD, Hruban RH, Thompson E, Aguirre AJ, Wolpin BM, Sasson A, Kim J, Wu M, Bucobo JC, Allen P, Sejpal DV, Nealon W, Sullivan JD, Winter JM, Gimotty PA, Grem JL, DiMaio DJ, Buscaglia JM, Grandgenett PM, Brody JR, Hollingsworth MA, O'Kane GM, Notta F, Kim E, Crawford JM, Devoe C, Ocean A, Wolfgang CL, Yu KH, Li E, Vakoc CR, Hubert B, Fischer SE, Wilson JM, Moffitt R, Knox J, Krasnitz A, Gallinger S, Tuveson DA.

Cancer Discov. 2018 Sep;8(9):1112-1129. doi: 10.1158/2159-8290.CD-18-0349. Epub 2018 May 31.

PMID:
29853643
4.

Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus.

Schrock AB, Pavlick D, Klempner SJ, Chung JH, Forcier B, Welsh A, Young L, Leyland-Jones B, Bordoni R, Carvajal RD, Chao J, Kurzrock R, Sicklick JK, Ross JS, Stephens PJ, Devoe C, Braiteh F, Ali SM, Miller VA.

Clin Cancer Res. 2018 Apr 15;24(8):1881-1890. doi: 10.1158/1078-0432.CCR-17-3103. Epub 2018 Jan 23.

5.

Genomic Profiling of Small-Bowel Adenocarcinoma.

Schrock AB, Devoe CE, McWilliams R, Sun J, Aparicio T, Stephens PJ, Ross JS, Wilson R, Miller VA, Ali SM, Overman MJ.

JAMA Oncol. 2017 Nov 1;3(11):1546-1553. doi: 10.1001/jamaoncol.2017.1051.

6.

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.

Kasikara C, Kumar S, Kimani S, Tsou WI, Geng K, Davra V, Sriram G, Devoe C, Nguyen KN, Antes A, Krantz A, Rymarczyk G, Wilczynski A, Empig C, Freimark B, Gray M, Schlunegger K, Hutchins J, Kotenko SV, Birge RB.

Mol Cancer Res. 2017 Jun;15(6):753-764. doi: 10.1158/1541-7786.MCR-16-0350. Epub 2017 Feb 9.

7.

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.

Wanchoo R, Karam S, Uppal NN, Barta VS, Deray G, Devoe C, Launay-Vacher V, Jhaveri KD; Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors.

Am J Nephrol. 2017;45(2):160-169. doi: 10.1159/000455014. Epub 2017 Jan 12. Review.

8.

Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia.

Fathi AT, DeAngelo DJ, Stevenson KE, Kolitz JE, Asch JD, Amrein PC, Attar EC, Steensma DP, Wadleigh M, Foster J, Connolly C, Galinsky I, Devoe CE, Stone RM, Neuberg DS, Ballen KK.

Cancer. 2016 Aug 1;122(15):2379-88. doi: 10.1002/cncr.30037. Epub 2016 May 12.

9.

Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancer.

Oroszi G, Brody J, Yang T, Allen SL, Devoe C, Zhang X.

Leuk Lymphoma. 2016 Nov;57(11):2689-92. doi: 10.3109/10428194.2016.1154960. Epub 2016 Apr 20. No abstract available.

PMID:
27095477
10.

BRAF inhibitors - do we need to worry about kidney injury?

Wanchoo R, Devoe C, Jhaveri KD.

Expert Opin Drug Saf. 2016 May;15(5):579-81. doi: 10.1517/14740338.2016.1164139. Epub 2016 Mar 22. No abstract available.

PMID:
26954036
11.

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.

Hingorani SR, Harris WP, Beck JT, Berdov BA, Wagner SA, Pshevlotsky EM, Tjulandin SA, Gladkov OA, Holcombe RF, Korn R, Raghunand N, Dychter S, Jiang P, Shepard HM, Devoe CE.

Clin Cancer Res. 2016 Jun 15;22(12):2848-54. doi: 10.1158/1078-0432.CCR-15-2010. Epub 2016 Jan 26.

12.

PEG-asparaginase induced severe hypertriglyceridemia.

Galindo RJ, Yoon J, Devoe C, Myers AK.

Arch Endocrinol Metab. 2016 Apr;60(2):173-7. doi: 10.1590/2359-3997000000068. Epub 2015 Aug 28. Review.

13.

A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use.

Baird P, Leung S, Hoang H, Babalola O, Devoe CE, Wanchoo R, Jhaveri KD.

J Oncol Pharm Pract. 2016 Apr;22(2):357-60. doi: 10.1177/1078155214568581. Epub 2015 Jan 14.

PMID:
25591868
14.

The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide.

Devoe CE, Li JY, Demopoulos AM.

J Neurooncol. 2014 Aug;119(1):217-20. doi: 10.1007/s11060-014-1475-5. Epub 2014 May 22. No abstract available.

PMID:
24847966
15.

Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature.

Hsu P, Yang T, Sheikh-Fayyaz S, Brody J, Bandovic J, Roy S, Laser J, Kolitz JE, Devoe C, Zhang X.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):1042-50. eCollection 2014. Review.

16.

Carfilzomib-related acute kidney injury.

Jhaveri KD, Chidella S, Varghese J, Mailloux L, Devoe C.

Clin Adv Hematol Oncol. 2013;11(9):604-5. No abstract available.

PMID:
24518527
17.

High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.

Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H.

Clin Cancer Res. 2013 Jul 1;19(13):3396-403. doi: 10.1158/1078-0432.CCR-12-3020. Epub 2013 May 8.

18.

Central nervous system lymphoma in immunocompetent patients: the North Shore-Long Island Jewish Health System experience.

Zhang X, Chen QH, Farmer P, Nasim M, Demopoulos A, Devoe C, Ranjan T, Eisenberg MB, Schulder M, Bi C, Li JY.

J Clin Neurosci. 2013 Jan;20(1):75-9. doi: 10.1016/j.jocn.2012.05.021. Epub 2012 Oct 23.

PMID:
23098391
19.

Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients.

Conte JE Jr, DeVoe C, Little E, Golden JA.

Antimicrob Agents Chemother. 2010 Sep;54(9):3609-13. doi: 10.1128/AAC.01396-09. Epub 2010 Jun 1.

20.

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE Jr.

Antimicrob Agents Chemother. 2010 Aug;54(8):3451-9. doi: 10.1128/AAC.01647-09. Epub 2010 May 3.

21.

IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization.

Schmidt VA, Scudder L, Devoe CE, Bernards A, Cupit LD, Bahou WF.

Blood. 2003 Apr 15;101(8):3021-8. Epub 2002 Dec 19.

22.

The effect of dyes used to evaluate the in situ, ex-vivo, and perfused kidney.

Burleson RL, Kasulke R, Jones DB, Marbarger P, DeRito J, DeVoe C.

Invest Urol. 1981 Nov;19(3):165-8.

PMID:
7298285
23.

Renal transplantation; therapeutic effectiveness at State University of New York Upstate Medical Center.

Burleson RL, Schroeder ET, Marbarger PD, Henry JB, Small Z, DeRito JR, DeVoe C.

N Y State J Med. 1979 Sep;79(10):1528-32. No abstract available.

PMID:
392341
24.

Clinical renal preservation by cryoperfusion with an albumin perfusate: renal perfusion with albumin.

Burleson RL, Jones DB, Yenikomshian AM, Cornwall C, DeVoe C, DeRito J.

Arch Surg. 1978 Jun;113(6):688-92.

PMID:
350192
25.

Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.

Burleson RL, Jones DB, Yenikomshian A, DeVoe C, DeRito J.

Transplant Proc. 1977 Sep;9(3):1591-6.

PMID:
331594
26.

Damage from methylene blue and indigo-carmine dye perfusion of kidneys.

Burleson RL, Jones DB, DeVoe C, DeRito J.

Surg Forum. 1977;28:551-3. No abstract available.

PMID:
364741
27.

Superiority of perfusion to Sacks' solution for twenty-four hour kidney preservation.

Burleson RL, Yenikomshian AM, DeRito J, DeVoe C.

Transplantation. 1976 Feb;21(2):168-70. No abstract available.

PMID:
766335

Supplemental Content

Support Center